The 15th IHEA World Congress on Health Economics will be held July 9-12, 2023, in Cape Town, South Africa, and our teams are prepping for our biggest attendance yet. Our projects will be featured in five pre-congress sessions all listed below, all of which are available for FREE virtual attendance.

The IHEA Congress is an international convention for health systems experts to discuss the latest data, methodologies, findings, and tools in the pursuit of improving health care around the globe. This year’s theme is “Diversity in Health Economics.” The event will take place in both buildings of the Cape Town International Convention Centre (CTICC). Find more information on ThinkWell’s IHEA pre-congress sessions, how to register, and the agenda below.

As more details around schedules become available, this page will be updated. See you in Cape Town!

Attend Pre-Congresses Virtually

Pre-Congress Registration

Pre-Congress Agenda

Pre-congress sessions will run July 8-9, 2023. ThinkWell will participate in five sessions detailed below.

Saturday, July 8

9 AM-12:30 PM

Organizers: ThinkWell, Center for Global Development, and KEMRI Wellcome Trust Research Programme

There is growing consensus that channeling funds to health facilities and granting them more autonomy will improve the delivery of primary health care services. In this session, we will explore the evidence about the impact of direct financing for facilities on access to health products, especially essential medicines.

People-Centred, Efficient Health Care Services: Rethinking Sustainable Health Care Financing in the Context of the African Union’s ALM Declaration on Domestic Financing for Health

1:30 PM-5 PM

Organizers: ThinkWell, The Global Fund, AUDA-NEPAD, Eastern African Community, ODI, and SADC

In uncertain times, the need to ensure that adequate, effective, and efficient financing for healthcare in Africa remains a political priority has never been clearer.  This is the goal at the heart of the African Unions ALM initiative on domestic financing for health. We hear from the organizations tasked with implementing that ambitious agenda, together with member states implementing their own health financing reform agendas.

9 AM-5 PM

The Immunization Economics Special Interest Group welcomes researchers to join a two-day meeting to take stock of the latest evidence and research projects, exchange research approaches and methods, and to discuss research priorities. Topics on the agenda will include costing, value of vaccines, immunization financing, and the use of economic evidence for policy and programming.

Register for this session here

Sunday, July 9

8:30 AM-12 PM

Organizers: ThinkWell, R4D, and WHO

This bilingual session (English-French) brings together diverse country experiences to discuss the latest research on contributory social health insurance and non-contributory/free healthcare schemes. The session facilitates an exchange between African, Asian, and Latin American speakers, explores the politics behind these reforms and how these schemes can be improved to achieve UHC.

1 PM-4:30 PM

The SDGs push all countries to achieve UHC by 2030; however, UHC will not be achieved unless sustainable health financing is in place. Many countries have inadequate comprehensive analyses of sustainable health financing. This session explores several health financing models and the respective performance of current UHC in four LMICs: Indonesia, the Philippines, India, and Sri Lanka.

8:30 AM-4:30 PM

The main IHEA congress will be held July 10-12, 2023. The detailed agenda for each presentation can be found HERE. Please visit this page to access titles, times, and descriptions for each presentation.

IHEA Congress Information

Congress Registration

Attend Pre-Congresses Virtually

Since 2011, ThinkWell has expanded access to high quality health services to underserved populations in low- and middle-income countries by addressing health system challenges that rarely get the attention they need. Universal health coverage lies at the center of our work, and while there are hundreds of initiatives to address hundreds more health issues, diseases, and economic gaps, global immunization is a unique opportunity to save lives, increase productivity and economic gains, and improve quality of life for individuals and families. What’s more, immunization is considered one of the most cost-effective investments available, which means that limited financial resources are well spent and have high health returns when invested in vaccines. 

While national governments, especially those of low- and middle-income countries, seek to expand national immunization programs to include newer vaccines, like those for human papillomavirus and dengue fever, the financing rarely matches the desired scale of these programs. Financing should not only cover the cost of procuring vaccines, but it should also cover increased investments in cold chain management and logistics, training of providers, and social mobilization and awareness-building efforts. So, while strong immunization programming is considered a “good buy,” it isn’t cheap and requires sustained investment. 

As the world’s immunization experts fortify global health systems with knowledge gained from COVID-19, ThinkWell’s immunization projects have continued to generate economic evidence informing planning and investment in vaccine delivery for marginalized people across the globe. Every day, our world moves closer to global immunization standards. Following this World Immunization Week, we’d like to celebrate the progress we’ve made as a global health community and look ahead to the steps yet to be taken. 

The Investment of a Lifetime 

According to the World Health Organization, before COVID-19, only 11% of public spending on health was for prevention in low- and middle-income countries, and governments account for less than half of total spending on disease prevention. Policymakers may place a high value on immunization and public health, yet many immunization budgets remain flat, as prevention results are far less visible than curative intervention. 

Financing shortfalls mean low vaccine adoption rates and variable coverage which compromises the efficacy of lifesaving vaccines. ThinkWell’s Sustainable Immunization Financing team has seen these patterns time and again, but the economic evidence behind the health returns on vaccines is too large to ignore. Our teams work with local experts and government officials in geographically diverse countries to develop financing evidence and policy recommendations built to withstand evolving sociopolitical agendas and unpredictable events like global pandemics. 

Relative to other health initiatives, immunization has excellent value-for-money and has proven itself an unfailing investment in current and future generations. To this end, advocates, civil society organizations, immunization program managers, and researchers alike can take the following actions to raise awareness and galvanize support: 

  1. Tell the full story of vaccination success to generate societal and political demand. 
  2. Create and maintain a shared agenda across the health advocacy spectrum. 
  3. Articulate the shared needs of the products, systems, and people involved in immunization. 
  4. Integrate immunization into primary health care. 

To champion routine immunization in the long term, advocates and immunization program managers need to provide ministers of health and finance a clear picture of what their countries would be facing without immunization programs. These steps are a clear way to push the immunization financing agenda forward. 

Immunization Equity 

Immunization programs and budgets require continuous honing and nuanced understanding of local needs and capacities. Once budgets are built and funds are earmarked, nations need to ensure that there is local capacity for education and deployment. The global immunization economics community churns out data around costs per dose, campaign financing, and workforce shortages daily. The Immunization Economics community of practice, managed by ThinkWell, is a conglomerate of researchers from all over who make their research public so that policymakers and civil society organizations can create efficient budgets and advocate for mass immunization in local communities. 

A global network of experts ensures that underserved populations whose health needs rarely get the required attention can access vaccines from childhood and reap the long-term health and economic benefits of stopping a disease before it starts. And when populations are vaccinated, fewer need intensive health care services later in life, reducing the economic burden on national health coverage schemes. 

Our Global Responsibility 

Health professionals in every country work tirelessly to reach new populations and deliver essential health services like vaccines in areas where demand is the greatest, but without visibility and increased support from national stakeholders, immunization will fall short of global goals and people who need them will not receive lifesaving vaccines. 

As we rebound from COVID-19 with boundless new information on budgeting for health crises and rapid vaccine deployment, knowledge-sharing is an indispensable way to make sure low- and middle-income countries have evidence on which to build sustainable immunization financing policy. 

When governments are equipped with current data, digestible research, and clear health goals, the value of vaccines will be made abundantly clear and immunization financing will become a health priority. Following World Immunization Week 2022 and beyond, ThinkWell joins the global health community to share ideas, research, and support for health professionals and researchers around the world and ensuring every person has access to lifesaving vaccines. 

Low- and middle-income countries (LMIC) are standing at the beginning of an incredibly challenging vaccine roll-out. COVID-19 vaccine delivery poses unprecedented challenges in terms of delivery volume, reaching new target populations, diversity of delivery strategies, and sometimes complex product profiles—elements that must all be managed at rapid speed if effective coverage is to be achieved. ThinkWell contributed to global level modeled estimates which indicate that the delivery cost of COVID-19 vaccines in LMIC-settings could be several times greater than for routine childhood vaccines. However, these estimates are based on crude assumptions and global level parameters, and real cost evidence from countries is lacking.

ThinkWell is conducting costing studies of COVID-19 vaccine delivery in Bangladesh, Côte d’Ivoire, and Mozambique, and 3-4 other countries to generate rapid economic evidence to support the sustainable roll-out of COVID-19 vaccines. In each country, bottom-up ingredients-based costing and top-down analysis of financial expenditure budgets and reports will be conducted to estimate the cost of delivering COVID-19 vaccines through various delivery strategies, reaching different target populations, and using products with varying cold chain requirements. The studies will also map out the service delivery process and funding flows and capture the source and use of different types of paid and volunteer health workers mobilized to deliver COVID-19 vaccines. Semi-structured interviews will also be conducted with stakeholders to assess the roll-out and its challenges. The studies will follow a common research protocol based on guidance on routine immunization costing methods and the standardized campaign costing methodology developed by ThinkWell.  You can read about previous immunization costing studies here. The first results are expected by April/May 2022.

This work is supported by funding from the Bill & Melinda Gates Foundation. To find out more about this project, please click here.

Nearly 200 attendees convened on October 19th and 20th for the Second Annual Health Campaign Effectiveness Coalition Meeting. The goals of the meeting were to identify promising practices and build consensus around actions to foster learning, collaboration, and systems to effectively plan and implement campaigns to deliver health services to priority populations. More than 50 speakers, moderators, and presenters, including ThinkWell economist Laura Boonstoppel, came together to share their knowledge and experiences in health campaigns around malaria, NTDs, polio, vaccine-preventable diseases, and nutritional supplementation.

Laura was part of the panel for an open discussion on the economic aspects of campaign integration alongside Dr. Alan Hinman of the Task Force for Global Health and Dr. Deborah McFarland of Emory University. This session included a rich conversation on the implications of campaign integration for health worker incentives and motivation, and how benefits and costs for households and beneficiaries are included in economic analyses. The recording of this session can viewed below and recordings of all of the other presentations and discussions can be viewed here.

Christina Banks and Flavia Moi presented a poster on findings from two costing studies on immunization campaigns in Nigeria and Sierra Leone which showed the potential financial efficiencies of campaign integration and the effect of volume delivered on cost per dose. This presentation prompted interesting discussions on how the cost of campaigns with multiple antigens or integrated nutritional interventions compares to single-antigen or vaccine-only delivery and the different staffing requirements of both. The poster can be viewed here and the full Sierra Leone study report can be read here.

For more information on ThinkWell’s campaign costing work, please visit the Immunization Costing Action Network page on